Xylem (XYL) Scheduled to Post Earnings on Thursday

Xylem (NYSE:XYL) is set to announce its earnings results before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.84 per share for the quarter. Xylem has set its FY 2024 guidance at 4.000-4.200 EPS.Investors that wish to listen to the company’s conference call can do so using this link.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.03. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.05 billion. During the same quarter last year, the firm posted $0.92 EPS. The business’s revenue for the quarter was up 40.6% on a year-over-year basis. On average, analysts expect Xylem to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Xylem Stock Performance

NYSE:XYL opened at $130.70 on Wednesday. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22. Xylem has a twelve month low of $87.59 and a twelve month high of $133.71. The firm has a market cap of $31.68 billion, a price-to-earnings ratio of 48.05, a price-to-earnings-growth ratio of 2.64 and a beta of 1.10. The company has a 50-day moving average of $127.91 and a 200-day moving average of $114.34.

Xylem Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were paid a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, February 20th. This is a positive change from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 1.10%. Xylem’s dividend payout ratio is currently 52.94%.

Insider Buying and Selling

In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at $360,682.15. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares in the company, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have commented on XYL. Oppenheimer upped their price objective on shares of Xylem from $133.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, April 18th. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Royal Bank of Canada upped their price objective on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Wednesday, February 7th. Stifel Nicolaus upped their price objective on shares of Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. Finally, BNP Paribas assumed coverage on shares of Xylem in a research report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price target for the company. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $138.11.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.